DigiPath Labs Advocating for Cannabis Industry Standards that Promote Public Safety and Health

Jul 23, 2015, 09:00 ET from DigiPath, Inc.

LAS VEGAS, July 23, 2015 /PRNewswire/ -- DigiPath, Inc. (OTCBB and OTCQB: DIGP), the independent cannabis testing and media firm, has joined the Coalition for Responsible Cannabis Production (CRCP), a nationally focused industry standards and production protocols organization.

DigiPath and CRCP are currently collaborating with the Conference of Western Attorneys General (CWAG) and the National Association of Attorneys General (NAAG) to address public health and safety issues related to the cannabis industry.

"Marijuana, as an ingestible product, needs to be safely produced in accordance with rigorous standards and protocols," said DigiPath CEO Todd Denkin. "We have moved well beyond allowing the medicinal use of cannabis. It is no longer an experiment. Voters are enacting laws legalizing cannabis use in cities and states across the country."

Denkin believes DigiPath and other businesses associated with cannabis production have an obligation to provide attorneys general and law enforcement officials with accurate and reliable information relating to this emerging industry.

"Only then can we collectively understand and articulate the impacts cannabis laws and policies can have on public health and safety," said Denkin. "It also becomes crystal clear that establishing rigorous standards is the only path that should be followed in addressing public safety and health concerns."

This week, Dr. Cindy Orser, Chief Science Officer of DigiPath Labs, shared relevant information with an audience of attorneys general during a panel discussion titled "Marijuana Legalization Update: Establishing Standards to Address Law Enforcement, Public Safety and Consumer Needs" at the CWAG Annual Meeting in Hawaii.

About DigiPath

DigiPath Labs utilizes state-of-the-art Agilent analytical instrumentation to quantify the presence of dozens of medicinal compounds like THC and CBD and potentially harmful contaminants such as pesticides, mycotoxins, microbes, heavy metals, and solvents used to make cannabis concentrates.

DigiPath Labs is a subsidiary of DigiPath, Inc., a diversified company that supports the cannabis industry's best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the nation.

For more information, go to www.digipath.com.

Information about Forward-Looking Statements

This press release contains "forward-looking statements" that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the demand for the Company's products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

DigiPath, Inc.
Investor Relations
702.209.2429
info@digipath.com

Photo - http://photos.prnewswire.com/prnh/20140605/94753

 

SOURCE DigiPath, Inc.



RELATED LINKS

http://www.digipath.com